A report by neurosurgeons at the Papa Giovanni XXIII Hospital in Bergamo, Italy, highlights the strategies their unit had to take to help combat the viral illness, which has claimed the lives of more than 1.49 million people worldwide. The study was published in the Journal of Neurosurgery in December 2020.
A new study reveals inequalities in the delay in screening for cervical cancer, and recommends that the screening capacity be increased in addition to giving a higher priority to women who have missed their scheduled visit.
On April 18, 2018, 7 suspected human anthrax cases were reported from the Kween District Health Office in Kween District, Uganda. Ugandan researchers from the Uganda Public Health Fellowship Program, Kampala, Uganda, have now published their findings on the outbreak’s source in the latest issue of the CDC’s (Centre for Disease Prevention and Control) Emerging Infectious Diseases.
A research team has reviewed the existing literature on compounds derived from molluscs used for treating respiratory diseases.
In a study published in the iScience journal, a research group from Switzerland shows that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptors and entry genes are expressed in the human olfactory neuroepithelial cells and brain by observing key molecular players implicated in the infectious process
We’ve all been there. Whether we’re stuck in traffic at the end of a long day, or eagerly anticipating the release of a new book, film or album, there are times when we need to be patient.
A recent study reveals that resveratrol, a phenolic compound produced by spermatophytes, can inhibit the viral replication SARS-CoV-2.
A team of researchers at the Robert Wood Johnson Medical School, Rutgers University, USA, have investigated a case wherein a man experienced recurrent episodes of Guillain–Barré Syndrome after being infected with SARS-CoV-2.
Researchers from the Centres for Disease Prevention and Control (CDC) have released findings of their study on the transmission of SARS-CoV-2 via international travel.
Funding from the National Institutes of Health will enable a Penn State researcher to study whether vitamin D supplementation could help people ward off or reduce symptoms caused by COVID-19.